High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
11 05 2021
Historique:
pubmed: 12 5 2021
medline: 20 5 2021
entrez: 11 5 2021
Statut: epublish

Résumé

We investigated likelihood to vaccinate and reasons for and against accepting a coronavirus disease 2019 (COVID-19) vaccine among adult residents of Finland. Vaccine acceptance declined from 70% in April to 64% in December 2020. Complacency and worry about side effects were main reasons against vaccination while concern about severe disease was a strong motive for vaccination. Convenience of vaccination and recommendations by healthcare workers were identified as enablers for vaccination among those aged under 50 years. Understanding barriers and enablers behind vaccine acceptance is decisive in ensuring a successful implementation of COVID-19 vaccination programmes, which will be key to ending the pandemic.

Identifiants

pubmed: 33972001
doi: 10.1017/S0950268821001114
pii: S0950268821001114
pmc: PMC8134886
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e123

Commentaires et corrections

Type : ErratumIn

Références

Pediatrics. 2017 Jan;139(1):
pubmed: 27940512
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Can Commun Dis Rep. 2020 Apr 02;46(4):93-97
pubmed: 32281992
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455

Auteurs

Charlotte C Hammer (CC)

Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Veronica Cristea (V)

Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Timothee Dub (T)

European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Jonas Sivelä (J)

European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH